(Q35927962)

11 August 2017

IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center (English)

1 reference

11 August 2017

8

David Azria

1 reference

11 August 2017

2

Pascal Fenoglietto

1 reference

11 August 2017

3

Claire Lemanski

1 reference

11 August 2017

6

Jean-Bernard Dubois

1 reference

11 August 2017

Carmen Llacer Moscardo

series ordinal

4

object named as

Carmen Llacer Moscardo

1 reference

11 August 2017

7

Norbert Aillères

1 reference

11 August 2017

5

Sophie Gourgou

1 reference

11 August 2017

1

Sabine Vieillot

1 reference

11 August 2017

23 March 2012

1 reference

11 August 2017

1 reference

11 August 2017

7

1 reference

11 August 2017

45

1 reference

Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342212

Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342212

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342212

Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342212

Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342212

Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342212

Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342212

The National Cancer Data Base report on carcinoma of the anus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342212

Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342212

The impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342212

The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy

11 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-45

Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-45

Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-45

Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-45

A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-45

Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-45

Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research

21 January 2018

1 reference

12 December 2020

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

1 reference

12 December 2020

Intensity-modulated radiation therapy for the treatment of anal cancer

1 reference

12 December 2020

An evaluation of combined therapy for squamous cell cancer of the anal canal

1 reference

12 December 2020

A new approach to the management of epidermoid carcinoma of the anal canal

1 reference

12 December 2020

Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy

1 reference

12 December 2020

Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1186/1748-717X-7-45

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

PubMed publication ID

22445137

1 reference